Tetraneuron
PrivateLast Round
VC Round
Dec 9, 2025
Total Funding Raised
$5.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tetraneuron is a biotechnology company that develops AAV-based gene therapies to treat Alzheimer's disease and other neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tetraneuron Comparables
Compare Tetraneuron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LEXEO Therapeutics | 77% | |
| VectorY Therapeutics | 74% | |
| AviadoBio | 74% | |
Tetraneuron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 9, 2025 | ||||
| Seed | Dec 27, 2022 |
Key People
Founding team and executive leadership
Tetraneuron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GIMIC Ventures | VC Round |
| Johnson & Johnson Innovation - JLABS | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2026
Grew 25% QoQ, from 16 to 20 employees.
- Dec 9, 2025
Raised $5.85M led by GIMIC Ventures
Tetraneuron Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tetraneuron's valuation, stock price, and market status.